DRKS00019198CompletedNot Applicable
ACP-autoantibody response in patients with early rheumatoid arthritis - AREPRA
Department Innere Medizin Klinik für Rheumatologie und Klinische Immunologie0 sites39 target enrollmentStarted: November 5, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 39
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to 100 Years (—)
- Sex
- All
Inclusion Criteria
- •Early rheumatoid arthritis with the diagnosis made less than 2 years before inclusion
Exclusion Criteria
- •Prior therapy with rituximab or cyclophosphamide
Investigators
Similar Trials
Recruiting
Not Applicable
Analysis of antibody production in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.rheumatic diseases1000381610023213rheumatoid arthritisNL-OMON42179Jan van Breemen Instituut30
Completed
Phase 4
The response of vasculitis patients to influenza vaccination compared to healthy individualsACTRN12608000440325Royal Adelaide Hospital100
Not yet recruiting
Unknown
Association of immunological response with the presence or absence of oral mood stabilizers in schizophrenia patients infected with COVID-19Patients with schizophreniaJPRN-UMIN000050395Kurita hospital50
Not yet recruiting
Not Applicable
Red cell antibody profile in Covid-19CTRI/2020/10/028567Seth GS Medical College and KEM Hospital
Recruiting
Not Applicable
Auto-antibody sequencing in patients with autoimmune myasthenia gravis and pemphigusPemphigusMGMyasthenia gravisNL-OMON50392eids Universitair Medisch Centrum80